Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1999
11/11/1999CA2328459A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
11/11/1999CA2327584A1 Attenuated influenza viruses
11/11/1999CA2327539A1 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/11/1999CA2326763A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and methods for their synthesis
11/11/1999CA2326402A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/10/1999EP0955545A1 Process to select bacterial strains
11/10/1999EP0955361A1 Monoclonal antibodies to tumor-associated antigens, methods for their production, and their use
11/10/1999EP0955312A2 Antimicrobial peptide
11/10/1999EP0955307A1 Erythromycin a derivatives and methods for the preparation thereof
11/10/1999EP0955061A1 Oral product for the prevention and therapy of porcine gastroenteric infections
11/10/1999EP0955059A2 Vaccines containing a saponin and a sterol
11/10/1999EP0955056A1 Recombinant colony stimulating factor-1 for treatment of fungal infection
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0954573A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
11/10/1999EP0954564A1 Methods for generating cytotoxic t cells in vitro
11/10/1999EP0954525A1 Novel compounds
11/10/1999EP0954333A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/10/1999EP0954332A1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
11/10/1999EP0954331A1 Novel compounds
11/10/1999EP0954325A1 Method for the specific immunoadsorption of selected pathogenic factors
11/10/1999EP0954310A1 Synergistic composition comprising rapamycin and calcitriol
11/10/1999EP0954309A1 Hiv and cancer treatment
11/10/1999EP0954296A1 Use of bronopol for the treatment of diseases in fish
11/10/1999EP0954288A1 Solid solution of an antifungal agent with enhanced bioavailability
11/10/1999EP0954278A1 Pharmaceutical compositions containing kukui nut oil
11/10/1999EP0765333B1 Quillaja saponin adjuvant and vaccine formulation containing same
11/10/1999EP0741737B1 Watersoluble azole antifungals
11/10/1999EP0635026B1 Novel lipophilic oligopeptides with immunomodulating activity
11/10/1999EP0544906B1 Antibacterial penem esters derivatives
11/10/1999EP0531447B1 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna
11/10/1999CN1234805A ICE inhibiting peptides
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234441A Recombined pure herpes virus built by using adhesive particles as basis and use thereof
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234276A Process for producing transfer factors resisting virus of respiratory tract
11/10/1999CN1234252A Medicinal liquor for treating anal fistula
11/10/1999CN1046291C Protein Rib, process for purification of the protein, reagent kit and pharmaceutical composition
11/10/1999CN1046288C Unsaturated phosphonates derivatives of purines
11/10/1999CN1046287C Substituted propane-2-OL derivatives, preparation method and fungicidal composition thereof containing same
11/10/1999CN1046276C Easters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones and use thereof
11/10/1999CN1046270C Pyrimidine-thloalkyl and alkylether compounds
11/10/1999CN1046269C HIV protease inhibitors
11/09/1999US5981762 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
11/09/1999US5981605 Containing more than 90% of a drying and/or protein coagulating, short-chained alcohol or alcohol mixture, primarily ethanol, and gelling agent; good skin-adhesive properties, matrix formation, forms a protective coating
11/09/1999US5981604 Materials and methods for inhibiting bacterial cell wall biosynthesis
11/09/1999US5981603 Antiviral agents
11/09/1999US5981601 Method for enhancing cellular bioenergy
11/09/1999US5981560 1,2,4-triazole fungicides
11/09/1999US5981537 Pyrimidine-thioalkyl and alkylether compounds
11/09/1999US5981528 Treating a bacterial infection
11/09/1999US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999US5981519 Useful for treatment and prophylaxis of infectious diseases, especially those caused by methicillin resistant staphylococcus aureus and pseudomonas aeruginosa
11/09/1999US5981494 Administering to the mammal a glycosidase inhibitor to inhibit the conversion of pro-toxin to toxin which causes maleria, endotoxic shock or septic shock in mammals
11/09/1999US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981479 Administering to the aids patient a nonimmunosuppressive, cyclophilin-bining cyclosporin which binds to human genetic engineered cyclophilin and has an activity in the mixed lymphocyte reaction of not more than 10% that of ciclosporin
11/09/1999US5981469 As antimicrobial drug, anticarcinogenic agent
11/09/1999US5981258 Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect
11/09/1999US5981229 For passive immune therapy; for diagnosis and prevention of grampositive bacterial infection; for prevention of infection by antibiotic resistant microoganisms
11/09/1999US5981213 Dna sequence coding microorganism outer membrane protein; detect the presence of antigens and/or antibodies in a sample; vaccine development
11/09/1999US5981170 Diagnostic immunoassay kit for detection of antibodies induced by human immunodeficiency virus in sample of body fluid; includes artificial peptide of an epitope having a cystine bridge
11/09/1999US5980913 A tetrapeptides as vaccine adjuvant
11/09/1999US5980910 Useful in coating polymeric medical materials to prevent colonization by coagulase-negative staphylococcal strains, in assays for the detection of such bacteria
11/09/1999US5980909 Epitopic regions of pneumococcal surface protein A
11/09/1999US5980908 A vaccine comprising an isolated fibronectin binding protein derived from staphylococcus aureus, by forming antibodies against the staphylococcus aureus bacterial strain
11/09/1999US5980907 Use in immunoprophylaxis
11/09/1999US5980906 Live recombinant avian vaccine using an avian herpesvirus as vector
11/09/1999US5980903 Composition for the treatment of viral infections including HIV
11/09/1999US5980901 Viral defective interfering particles and uses thereof
11/09/1999US5980900 Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus (HIV-1)
11/09/1999US5980899 Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
11/09/1999US5980897 Treating mammals suffering from infections caused by gram-negative bacteria
11/09/1999US5980895 Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation
11/09/1999US5980884 Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
11/09/1999US5980827 Passing air containing airborne microorganisms through air path means and disinfecting air in said path means by passing air over demand disinfectant resin such that airborne microorganisms contact said resin and are devitalized thereby,
11/09/1999CA2102321C Partial liquid breathing of fluorocarbons
11/09/1999CA2065111C Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
11/09/1999CA1340817C Recombinant flagellin vaccines
11/06/1999CA2270847A1 Alpha-ketoamide derivatives
11/04/1999WO1999055900A2 Gcp
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055875A2 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS)
11/04/1999WO1999055873A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999WO1999055860A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999WO1999055847A2 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus
11/04/1999WO1999055845A1 Cellular and animal models for diseases associated with altered mitochondrial function
11/04/1999WO1999055830A2 Process for synthesizing cox-2 inhibitors
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055730A2 Polyepitope carrier protein
11/04/1999WO1999055729A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES
11/04/1999WO1999055715A2 Polysaccharide-antigen conjugates
11/04/1999WO1999055713A1 Phosphonic diester derivatives
11/04/1999WO1999055711A1 Treatment of mastitis
11/04/1999WO1999055704A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof
11/04/1999WO1999055677A1 Quinolones used as mrs inhibitors and bactericides
11/04/1999WO1999055676A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
1 ... 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 ... 1798